Delivery Order SPE2DB25D3306-SPE2DB25FUBYC

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ONFI 10 MG TABLET 100S. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $9,313.73 and a performance period extending through June 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,374.45, is for the delivery of ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the procurement of a specific pharmaceutical product, ONFI 10 MG TABLET 100S. The contract has a ceiling value of $4,310.34 and a completion date of January 15, 2025. The contract is a firm-fixed-price delivery order, with no set-aside requirement indicated. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,683.44, is a firm fixed-price delivery order for 4,568,105,655 units of the pharmaceutical product ONFI 10 MG TABLET 100S. The contract has an ultimate completion date of May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONFI 10 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $8,510.23 and a completion date of May 22, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
This federal contract award, valued at $5,493.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of ONFI 10 MG TABLET 100S, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of May 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,795.48, is for the delivery of ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) contract, with a period of performance through June 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ONFI 10 MG TABLET 100S. The contract has a ceiling value of $6,318.25 and a period of performance through June 16, 2025. It is a firm fixed-price contract, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has a ceiling value of $11,606.49 and is a firm fixed-price delivery order. It is not designated as a set-aside contract, indicating open competition. The contract has an ultimate completion date of May 14, 2025....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $1,928.75, is for the supply of 4565379491 - ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 8, 2024. This award is not associated with a set-aside program. Amerisourcebergen has been awarded numerous...
  • SPE2DB25D3306
    Indefinite Delivery Contract
  • SPE2DB25D3306-SPE2DB25FUBYC
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONFI 10 MG TABLET 100S, with a ceiling value of $3,683.44 and a completion date of June 11, 2025. The contract is a firm fixed-price, non-set-aside award.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This contract allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/9/25, 12:44 PM